Work

Phase I/II Study of Liposomal Doxorubicin (DOX) in Combination with Selinexor (SEL) and Dexamethasone (Dex) for Relapsed and Refractory Multiple Myeloma (RRMM)

Year: 2017

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.3095.3095

Authors: Rachid Baz, Jeffrey A. Zonder, Kenneth H. Shain, Melissa Alsina, Jason Brayer, Mark Melody, Joel G. Turner, Jana L. Dawson, Jongphil Kim, Daniel M. Sullivan

Institutions: Moffitt Cancer Center, The Barbara Ann Karmanos Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2783293025

FWCI: 0.422

Cites:

Cited by: 9

Related to: 10